Closed-Loop Insulin System Boosts Diabetes Control in Pregnancy | CIRCUIT Trial

Type 1 diabetes pregnancy glycemic control closed-loop insulin system CIRCUIT trial results
Discover how a closed-loop insulin delivery system is revolutionizing diabetes management for pregnant women with type 1 diabetes. The CIRCUIT trial revealed that women using the Tandem t:slim X2 pump with Control-IQ spent 3 more hours daily in the target glucose range of 63-140 mg/dL compared to standard care.
Key findings include:
- Over 65% time in range versus 50% with standard care
- Reduced time above and below target
- Lower HbA1c and glucose levels
- Improved sleep quality
This system adapts to pregnancy needs, potentially reducing risks like preeclampsia and preterm births. Learn about the trial details, comparisons to other studies like CRISTAL and AiDAPT, and expert insights on optimizing diabetes tech for expectant mothers.
Stay informed on advancements in diabetes technology and maternal health.

Видео Closed-Loop Insulin System Boosts Diabetes Control in Pregnancy | CIRCUIT Trial канала Ever Changing